Medical Affairs Expert

Seasoned Global Medical Affairs leader with extensive experience systematically building and managing relationships with key opinion leaders, clinicians, investigators, scientific societies, and patient organizations across multiple therapy areas

Proven expertise in KOL strategy, mapping, segmentation & engagement/management plans across Europe

Well-versed in building sustainable results, created a fully integrated Medical Affairs structure covering Europe, the US, LATAM, and the Middle East

We have recruited this consultant before with excellent feedback; The contracts were extended multiple times

Integrated Medical Affairs & cross-functional leadership

Seasoned Global Medical Affairs leader with interim management experience at the intersection of Medical, Marketing, Market Access, and Regulatory

Advised boards on corporate governance and strategic oversight, including global and regional strategy reviews

Strong focus on strategic positioning, disease awareness, and evidence-based communication

KOL Strategy & Stakeholder Engagement

Extensive experience systematically building and managing relationships with key opinion leaders, clinicians, investigators, scientific societies, and patient organizations across multiple therapy areas (incl. oncology, hematology, neurology, dermatology)

Proven expertise in identifying, segmenting, and targeting opinion leaders and physicians, including market mapping and strategic targeting as part of launch and pre-launch activities

Governance development for long-term, sustainable KOL management strategy

Advisory boards & scientific events: Independent planning, selection, and execution of advisory boards, congresses, and satellite symposia — including speaker briefings, material development, and full ownership of international events across multiple therapy areas

Additional experience includes (pre-) launch planning, value dossier contribution, authority meetings, development of disease awareness campaigns, internal trainings, clinical study support, medical evidence generation

KOL Strategy: Conceptualization and structuring of a sustainable KOL engagement strategy, including action planning

KOL Mapping & Segmentation: Building a database of (neuro)oncological treatment centers and opinion leaders who treat gliomas and/or melanomas

KOL Development: Contacting clinicians who might be interested in initiatives for early access for their patients

Early Access: Identifying potential pathways for early access for clinicians/patients to support such initiatives

Governance development for long-term, sustainable KOL management

SOPs: Contributing to the local development of SOPs to ensure compliance with the highest ethical and legal standards

Provision of independent scientific expertise in relation to the development of the scientific agenda for an Advisory Boar

Contribution of medical-scientific input to the conceptual structuring of discussion topics in the therapeutic context

Provision of expert perspectives regarding the scientific relevance and content of potential program elements

KOL identification and recommendation of suitable scientific experts for potential participation in the Advisory Board based on relevant expertise

Scientific exchange with invited experts in relation to the thematic scope of the Advisory Board

Contribution of expert perspectives regarding potential scientific contributions of participating experts

Professional exchange with the client regarding scientific aspects of the proposed agenda and expert profiles

Participation in the Advisory Board meeting in an expert capacity

Medical-scientific and strategic (evidence-based) input based on close cross-functional collaboration with Market Access, Marketing, Commercial, Drug Safety, Corporate Affairs and other Brand functions

Planning, preparation, implementation, and summary of Medical Advisory Boards

Planning, preparation, and implementation of relevant (national) congresses and training events, including selection of suitable speakers for symposia, advice on the preparation and finalization of presentations and stand planning (medical)

Advice on publications

Advice and preparation for meetings with authorities

Pre-launch preparation:

• Selection and management of external experts

• Development of a corresponding network

• Definition of the "patient journey"

• Participation in international meetings

• Medical-scientific approval of various promotional and non-promotional materials

Consultancy on the development of medical affairs programs

Review scientific literature to provide advice to medical and marketing groups in developing strategy and tactical implementation plans

Contribute to the development of and maintain awareness of the competitive landscape and communicate intelligence to the medical and marketing team as appropriate

Providing strategic input into brand planning processes to ensure medical and scientific credibility and the optimal use of data for competitive product differentiation

Preparation of tailored clinical data packages for advisory boards, investigators and other key external experts

Cross-functional collaboration: Close collaboration between medical and commercial by consulting on the development of brand plans, the execution of the brand plans and key account excellence

Development of study plans to provide data for products in phase IV, observational and pharmaco-economic studies

Operational tasks, such as: Medical information, medical education, congress reporting, publication planning, presentations…)

Launch preparation from a medical perspective

Management of the early access programme

Support in day-to-day business

Planning and organisation of advisory boards/symposia/events

KOL management – expansion and development

Support and training for MSLs

Cross-functional collaboration (launch team, global teams)